New Jersey, February 15th, 2009–HepTronik Corp., has announced new alliance with Integra LifeScience.

Integra LifeScience

Integra is a market-leading, innovative medical device company focused on helping the medical professional enhance the standard of care for patients. Integra provides customers with clinically relevant, innovative and cost-effective products that improve the quality of life for patients.

HepTronik Corp has announced new alliance with Clean Earth Technologies, TechData Services, Trustek Inc.

Clean Earth Technologies is a premiere science and technology firm developing products and technologies, as well as providing services in intelligence, defense, homeland security, and life science.

TechData Services provides the best clinical research and highest outsourcing services for various clients in United States of America

Trustek Inc. is a software research, development and consulting company, focusing on ERP, E-Business and Internet technologies.

Nostrum Pharmaceuticals Inc., NJ chooses HepTronik Corp for clinical trial applications.

New Jersey, HepTronik Corp., a growing web based clinical trial application development company, has announced a new venture with Nostrum Pharmaceuticals Inc., NJ. Nostrum Pharmaceuticals will be adopting HepTronik Corporation web based clinical trial applications to conduct their series of clinical trials.

"We are pleased to provide this technology for Nostrum," said HepTronik President and CEO.

"We view this alliance with HepTronik as an integral part of our future success," said Nirmal Mulye, Nostrum Pharmaceuticals President.

HepTronik Corp., has announced a new venture with Hexagon Labs. Inc., NJ.

New Jersey, September 20, 2006– HepTronik Corp., has announced a new venture with Hexagon Labs. Inc., NJ which will be adopting HepTronik's web based market research applications to conduct their series of market research. We are team-oriented professionals and our aim is to be the first choice in the industry for alliances and collaborations that bring mutual benefits to each party. Collaborations with leading Pharmaceutical and biotechnology companies, and of innovative products and technologies, complement our in-house capabilities and play a key role in strengthening our commitment.

"We are pleased to provide this unique combination of domain and technology for Hexagon Labs, Inc." said HepTronik President and CEO.

"This alliance reinforces the value of our development platform and enables the next wave of products beyond our lead candidate drugs." said Dr.Reddy, President and Chief Executive Officer of Hexagon Labs.

"By partnering with HepTronik, a global leader in market/clinical research and development, we take a major step towards bringing a portfolio of highly targeted and effective drugs to patients." Dr.Reddy continued.

"This collaboration further strengthens our position at the forefront research, allowing us to combine our core expertise with HepTronik’s expertise in the early development. Also,this alliance adds to our proven expertise with market research and has the potential to significantly broaden and strengthen Hexagon labs." said K.Anjan, Chief Financial Officer of Hexagon Labs.

SAS Clinical Trial Program

Please click here for address and directions.

The open house session will provide an opportunity to learn about the SAS Clinical Trial Program. The consultants undertaking this will be present at the open house to discuss regarding the following and to assist you.

For those who cannot attend the open house, and interested in SAS please complete the registration form by clicking here

Additional information related to this openhouse or SAS can be obtained by contacting at 609-452-6005/609-233-8840 or by sending an email to kumar@heptronik.com.